Nov 15, 2023 / 09:30AM GMT
Glen Joseph Santangelo - Jefferies LLC, Research Division - Equity Analyst
Good morning, everybody. Thank you for joining us. We're excited to be hosting Viatris here with us today. Joining us from the company is Scott Smith, CEO, gentleman in the middle; to his left, Rajiv Malik, the President; and to Scott's far right over there Sanjeev Narula, the CFO; and Bill Szablewski, (inaudible) who heads Capital Market, he also (inaudible) Investor Relations (inaudible).
Today's format is just going to be a question-and-answer session. So we'll hope we'll try to get through this as fast as possible. For those of you who don't know me, I'm Glen Santangelo, I cover the specialty pharma, company operation, technology sectors at Jefferies and the analyst responsible for coverage of Viatris. So with that why don't we get started.
Questions and Answers:
Glen Joseph Santangelo - Jefferies LLC, Research Division - Equity AnalystScott it's been an interesting 8 months since you took over as CEO, a lot going on this year. The company transformation really
Trustpilot
